Inventor
Craig Husfeld
Inventor
Redwood City, CA, US
Overview
Patents· 77 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes20%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
C07KPeptides2%
C07CAcyclic or carbocyclic compounds1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium0%
PatentTitleYear
10,851,123Prodrugs of phenolic TRPV1 agonists202010,821,105Prodrugs of phenolic TRPV1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia202010,717,712Pegylated prodrugs of phenolic TRPV1 agonists202010,570,092Biphenyl compounds useful as muscarinic receptor antagonists202010,343,995Biphenyl compounds useful as muscarinic receptor antagonists201910,106,503Biphenyl compounds useful as muscarinic receptor antagonists201810,028,945Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof20189,926,272'Biphenyl compounds useful as muscarinic receptor antagonists'20189,585,963'Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof'20179,499,581'Compositions comprising enzyme-cleavable oxycodone prodrug'20169,493,477'Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof'20169,452,161'Biphenyl compounds useful as muscarinic receptor antagonists'20169,359,316'Prodrugs of phenolic TRPV1 agonists'20169,283,183'Biphenyl compounds useful as muscarinic receptor antagonists'20169,216,971'Quaternary ammonium compounds useful as muscarinic receptor antagonists'20159,139,612'Active agent prodrugs with heterocyclic linkers'20159,095,627'Opioid prodrugs with heterocyclic linkers'20159,040,032'Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof'20158,962,547'Compositions comprising enzyme-cleavable oxycodone prodrug'20158,912,334'Biphenyl compounds useful as muscarinic receptor antagonists'20148,815,907'Quaternary ammonium compounds useful as muscarinic receptor antagonists'20148,802,856'Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists'20148,785,633'Guanidine-containing compounds useful as muscarinic receptor antagonists'20148,685,916'Opioid prodrugs with heterocyclic linkers'20148,618,131'Biphenyl derivatives'20138,592,453'Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists'20138,569,228'Compositions comprising enzyme-cleavable oxycodone prodrug'20138,557,997'Biphenyl compounds useful as muscarinic receptor antagonists'20138,501,776'Biphenyl compounds useful as muscarinic receptor antagonists'20138,497,237'Compositions comprising enzyme-cleavable oxycodone prodrug'20138,492,407'Quaternary ammonium compounds useful as muscarinic receptor antagonists'20138,450,362'Amidine-containing compounds useful as muscarinic receptor antagonists'20138,399,488'Biphenyl compounds useful as muscarinic receptor antagonists'20138,378,121'Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists'20138,338,424'Guanidine-containing compounds useful as muscarinic receptor antagonists'20128,273,894'Biphenyl compounds useful as muscarinic receptor antagonists'20128,242,138'Amidine-containing compounds useful as muscarinic receptor antagonists'20128,202,891'Quaternary ammonium compounds useful as muscarinic receptor antagonists'20128,198,304'Guanidine-containing compounds useful as muscarinic receptor antagonists'20128,173,815'Biphenyl compounds useful as muscarinic receptor antagonists'20128,134,006'Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity'20128,119,796'Biphenyl compounds useful as muscarinic receptor antagonists'20128,080,565'Substituted 4-amino-benzylpiperidine compounds'20118,067,439'Biphenyl compounds useful as muscarinic receptor antagonists'20118,053,448'Biphenyl compounds useful as muscarinic receptor antagonists'20118,039,489'Guanidine-containing compounds useful as muscarinic receptor antagonists'20118,034,946'Biphenyl compounds useful as muscarinic receptor antagonists'20118,017,783'Biphenyl compounds useful as muscarinic receptor antagonists'20118,017,617'Amidine-containing compounds useful as muscarinic receptor antagonists'20118,013,152'Biphenyl compounds useful as muscarinic receptor antagonists'20117,960,385'Guanidine-containing compounds useful as muscarinic receptor antagonists'20117,910,608'Biphenyl compounds useful as muscarinic receptor antagonists'20117,879,879'Biphenyl derivatives'20117,868,175'Biphenyl compounds useful as muscarinic receptor antagonists'20117,851,632'Biphenyl compounds useful as muscarinic receptor antagonists'20107,851,631'Biphenyl compounds useful as muscarinic receptor antagonists'20107,834,185'Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists'20107,803,812'Biphenyl compounds useful as muscarinic receptor antagonists'20107,728,144'Biphenyl compounds useful as muscarinic receptor antagonists'20107,687,521'Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity'20107,683,173'Biphenyl compounds useful as muscarinic receptor antagonists'20107,629,336'Biphenyl compounds useful as muscarinic receptor antagonists'20097,585,879'Biphenyl compounds useful as muscarinic receptor antagonists'20097,557,126'Diphenylmethyl compounds useful as muscarinic receptor antagonists'20097,550,595'Biphenyl compounds useful as muscarinic receptor antagonists'20097,524,965'Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity'20097,521,041'Biphenyl compounds useful as muscarinic receptor antagonists'20097,501,442'Biphenyl compounds useful as muscarinic receptor antagonists'20097,491,736'Biphenyl compounds useful as muscarinic receptor antagonists'20097,479,562'Biphenyl compounds useful as muscarinic receptor antagonists'20097,368,463'Substituted 4-amino-1-benzylpiperidine compounds'20087,288,657'Biphenyl compounds useful as muscarinic receptor antagonists'20077,285,564'Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds'20077,265,133'Biphenyl compounds useful as muscarinic receptor antagonists'20077,262,205'Biphenyl compounds useful as muscarinic receptor antagonists'20077,250,414'Diphenylmethyl compounds useful as muscarinic receptor antagonists'20077,141,671'Biphenyl derivatives'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2013Patents assigned to THERAVANCE INC (51)· patent assignee history
2006–2020Based in Redwood City, CA, US· patent location history
2011–2016Patents assigned to HUSFELD CRAIG (25)· patent assignee history
2011–2016Patents assigned to JI YUHUA (22)· patent assignee history
2011–2016Patents assigned to MU YONGQI (22)· patent assignee history
2011–2016Patents assigned to LI LI (17)· patent assignee history
2013–2020Based in San Mateo, CA, US· patent location history
2014–2016Based in San Carlos, CA, US· patent location history
2020Based in San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| THERAVANCE INC | 51 | 2006–2013 |
| HUSFELD CRAIGself | 25 | 2011–2016 |
| JI YUHUA | 22 | 2011–2016 |
| MU YONGQI | 22 | 2011–2016 |
| LI LI | 17 | 2011–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Redwood City, California, US | 62 | 2006–2020 |
| San Mateo, California, US | 12 | 2013–2020 |
| San Carlos, California, US | 2 | 2014–2016 |
| San Francisco, California, US | 1 | 2020 |